Cinctive Capital Management LP Biogen Inc. Transaction History

Cinctive Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $975,438 - $1.23 Million	-5,034 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $111,960 - $143,885	500 Added 11.03%	5,034 $1.21 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $1.28 Million - $1.67 Million	4,534 New	4,534 $1.28 Million

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Cinctive Capital Management LP with notifications on news.